| Pharmaceutical Information |
| Drug Name |
Terbutaline |
| Drug ID |
BADD_D02162 |
| Description |
Terbutaline was first synthesized in 1966[A230333] and described in the literature in the late 1960s and early 1970s.[A230328] It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.[A230333,L32093,L32098]
Terbutaline was granted FDA approval on 25 March 1974.[L32088] |
| Indications and Usage |
Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.[L32093,L32098] |
| Marketing Status |
approved |
| ATC Code |
R03AC03; R03CC03 |
| DrugBank ID |
DB00871
|
| KEGG ID |
D08570
|
| MeSH ID |
D013726
|
| PubChem ID |
5403
|
| TTD Drug ID |
D0M8RC
|
| NDC Product Code |
Not Available |
| UNII |
N8ONU3L3PG
|
| Synonyms |
Terbutaline | Asthmoprotect | Brethaire | Brethine | Bricanyl | Terbasmin | Bricanyl SA | Butaliret | Butalitab | Contimit | KWD-2019 | KWD 2019 | KWD2019 | Monovent | Taziken | Tedipulmo | Terbul | Terbutalin AL | Terbutalin Stada | terbutalin von ct | Terbutalin-ratiopharm | Terbutalin ratiopharm | Terbutaline Sulfate | Terbuturmant | Arubendol |
|
| Chemical Information |
| Molecular Formula |
C12H19NO3 |
| CAS Registry Number |
23031-25-6 |
| SMILES |
CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
